• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Neurotech International

Neurotech International

ASX:NTI

  • Home
  • Corporate
    • Board and Management
    • Corporate Directory
    • Corporate Governance
  • Development Programs
    • Biopharmaceutical Trials
    • Combination Therapy
    • Pathways to Commercialisation
    • Mente Technology
  • Investors
    • Investor Dashboard
    • ASX Announcements
    • Company Reports
    • Presentations
    • Research
    • News & Media
  • Contact

News &
Media

  • Neurotech International: Quarterly Investor Conference Call with Dr Thomas Duthy

    30 January 2023

    Listen to the audio here | Time: 14.21

    View More
  • SBS News: New study examines medicinal cannabis treatment for people with autism

    19 November 2022
    SBS News

    Listen to the episode here | Time: 5.02

    View More
  • Sydney Morning Herald: Medicinal cannabis shows promising results for children with autism

    19 November 2022
    Sydney Morning Herald

    A groundbreaking new trial of medicinal cannabis has uncovered some promising results for families of children living with autism

    View More
  • 7NEWS: Medical cannabis trial for children living with Autism

    18 November 2022
    7News
    View More
  • ABC Radio: Melbourne study explores medicinal cannabis as treatment for children with autism

    18 November 2022
    ABC

    Professor Michael Fahey, spoke with Virginia Trioli on ABC Mornings

    Listen to the full ABC interview here | Time: 9m

    View More
  • Herald Sun: ‘Medicinal cannabis gave me my Autistic child back’

    18 November 2022
    Herald Sun

    A groundbreaking medicinal cannabis trial has had surprising results for children living with autism, with one mother declaring she’s got her “child back”.

    See the Herald Sun for full article

    View More
  • South West Connect Conference Presentation: Video

    24 October 2022
    South West Connect

    Executive Director, Dr Tom Duthy presents Neurotech International at the South West Connect Conference on the 21st October, 2022. Watch the video recording here.

    View More
  • Neurotech International is anticipating results from its extended world first study of a medicinal cannabis product in children which could be a game-changer in autism treatment.

    21 September 2022
    Stockhead

    Neurotech is anticipating results from its extended world first study of a medicinal cannabis product in children which could be a game-changer in autism treatment. Read the full story here.

    View More
  • ASX Small & Mid-Cap Conference: Neurotech International Limited

    20 September 2022
    ASX

    Executive Director, Dr Tom Duthy presents Neurotech International at the ASX Small and Mid-Cap Conference on the 14th September, 2022. Watch the video recording here.

    View More
1 2 3 … 5
Next

Footer

Suite 5 CPC, 145 Stirling Highway
Nedlands WA 6009
Australia

moc.l1675270095anoit1675270095anret1675270095nihce1675270095torue1675270095n@ofn1675270095i1675270095

+61 (8) 9389 3130

Subscribe to our latest announcements

Name*
This field is for validation purposes and should be left unchanged.

Copyright © 2023 Neurotech International • Site by White Noise Communications

Download prospectus